Abstract:Dystonia musculorum (dt(J)/dt(J)) mutant mice suffer from a degeneration of spinocerebellar tracts as well as a dystrophy of peripheral sensory tracts. This neurological mutant has been proposed as an animal model of human cerebellar ataxia, in particular of the Friedreich's type; thus, it was deemed of interest to examine the endogenous contents of dopamine (DA) and metabolites as well as the distribution of DA receptors of the D(1) and D(2) subtypes, in order to delimit the biochemical characteristics of this pathological disorder, and determine an eventual dopaminergic dysfunction in this mutant. Tissue DA and its major metabolites 3, 4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine were measured by HPLC coupled to electrochemical detection in six cortical regions, in four divisions of rostral neostriatum and two halves of caudal neostriatum, as well as in olfactory bulb, nucleus accumbens, septum, amygdala, hippocampus, thalamus, hypothalamus, brainstem, cerebellum, substantia nigra, and ventral tegmental area. The only significant difference between dt(J)/dt(J) mice and wild-type controls was an increase in hypothalamic DA contents (+47%). Quantitative autoradiography with [(3)H]SCH23390 and [(3)H]raclopride, to label D(1) and D(2) receptors, respectively, revealed only moderate changes in receptor densities in a few localized regions. In dt(J)/dt(J) mutants, D(1) receptor numbers were found to be higher in thalamus (+27%) as well as in the medio-dorsal (+16%) and in the latero-dorsal (+16%) quadrants of rostral neostriatum, while D(2) receptor densities were greater in the medio-ventral (+32%) and the latero-dorsal (+17%) quadrants. The present results indicate an overall conservation of dopaminergic functions, albeit the few localized sites of increased D(1) and D(2) receptor densities, and that are seemingly independent of the DA innervation pattern, as revealed by the tissue measurements of DA and metabolites. They also rule out a major pathology linked to deficits in DA neurotransmission, and validate this mutant as an animal model of human cerebellar ataxia, probably of the Friedreich type.

Dopamine D3 Receptor Mutant and Wild-Type Mice Exhibit Identical Responses to Putative D3 Receptor-Selective Agonists and Antagonists.

Assessment Of Dopamine D3 Receptor Function Using D3 Receptor Knockout Mice

Alterations in Dopamine Release but Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.

Unraveling Dopamine D3 Receptor Function in Response to Psychostimulants Using a Genetic Approach.

Dopamine D1 Receptor Mutant Mice Are Deficient in Striatal Expression of Dynorphin and in Dopamine-Mediated Behavioral Responses

Alterations In Dopamine Neurotransmission Produced By Genetic Knockouts Of Dopamine D1 Receptors

Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor.

Dopamine D3 Receptor Regulates Basal but Not Amphetamine-Induced Changes in Pain Sensitivity in Mice

Elimination of Cocaine-Induced Hyperactivity and Dopamine-Mediated Neurophysiological Effects in Dopamine D1 Receptor Mutant Mice

Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.

Cellular Responses to Psychomotor Stimulant and Neuroleptic Drugs Are Abnormal in Mice Lacking the D1 Dopamine Receptor

Probing the Role of the Dopamine D1 Receptor in Psychostimulant Addiction

7-OH-DPAT and PD 128907 Selectively Activate the D3 Dopamine Receptor in a Novel Environment

Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents

Role of Dopamine D3 Receptors in Methamphetamine-Induced Behavioural Sensitization and the Characterization of Dopamine Receptors (D1R–D5R) Gene Expression in the Brain

Selectivity and Activation of Dopamine D3R from Molecular Dynamics

Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis

Dopamine D3 Receptor Modulates L-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling

Dopamine Receptor D1 but Not D3 Essential for Morphine-Induced Conditioned Responses